# Natalizumab (Genetical Recombination) I.V. Infusion 300mg (タイサブリ点滴静注３００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 1190402A1028). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 1190402A1028
- **Product name (Japanese):** タイサブリ点滴静注３００ｍｇ
- **English title:** Natalizumab (Genetical Recombination) I.V. Infusion 300mg
- **Active ingredient:** ナタリズマブ（遺伝子組換え）
- **Active ingredient (INN):** Natalizumab (Genetical Recombination)
- **Strength / unit:** ３００ｍｇ１５ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 11 Central nervous system agents (中枢神経系用薬) › 119 Other CNS agents (その他の中枢神経系用薬)
- **Manufacturer:** Biogen Japan (バイオジェン・ジャパン)
- **NHI price (reference only):** JPY 230345 per ３００ｍｇ１５ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/1190402A1028
- **JSON:** https://www.nifujipharma.com/api/drugs/1190402A1028

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Natalizumab%20(Genetical%20Recombination)%20I.V.%20Infusion%20300mg%20(%E3%82%BF%E3%82%A4%E3%82%B5%E3%83%96%E3%83%AA%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%93%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%201190402A1028#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.